Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | blood |
PMID[15651086] |
||
NPO5241 | Myristica fragrans | Species | Myristicaceae | Eukaryota | TCM_Taiwan* | |||
NPO12468 | Asarum heterotropoides | Species | Aristolochiaceae | Eukaryota | TM-MC* | |||
NPO6336 | Asarum sieboldii | Species | Aristolochiaceae | Eukaryota | TM-MC* | |||
NPO4659 | Asiasarum heterotropoides | NA | NA | NA | TM-MC* | |||
NPO29078 | Asiasarum sieboldii | NA | NA | NA | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT605 | Organism | Homo sapiens | Homo sapiens | Ratio | ~ | 1 | 11384238 | |
NPT1386 | Protein Family | Adrenergic receptor beta | Homo sapiens | Activity | = | 4.14 | 10.1016/S0960-894X(97)00046-2 | |
NPT4558 | Individual Protein | Beta-1 adrenergic receptor | Rattus norvegicus | ED50 | = | 0.091 | mg/kg | 6142955 |
NPT4663 | Individual Protein | Beta-2 adrenergic receptor | Canis lupus familiaris | ED50 | = | 2.13 | mg/kg | 6142955 |
NPT4333 | Protein Family | Adrenergic receptor beta | Rattus norvegicus | ED30 | > | 1000 | ug kg-1 | 6142955 |
NPT4913 | Individual Protein | Beta-1 adrenergic receptor | Cavia porcellus | Kd | = | 23.99 | nM | 6134834 |
NPT4914 | Individual Protein | Beta-2 adrenergic receptor | Cavia porcellus | Kd | = | 1174.9 | nM | 6134834 |
NPT5860 | Others | Adrenergic receptor beta; ADRB1 & ADRB2 | Homo sapiens | Ratio | = | 49 | 6134834 | |
NPT4558 | Individual Protein | Beta-1 adrenergic receptor | Rattus norvegicus | ED50 | = | 0.091 | mg/kg | 6138435 |
NPT4663 | Individual Protein | Beta-2 adrenergic receptor | Canis lupus familiaris | ED50 | = | 2.13 | mg/kg | 6138435 |
NPT4333 | Protein Family | Adrenergic receptor beta | Rattus norvegicus | ED30 | > | 1000 | ug kg-1 | 6138435 |
NPT288 | Individual Protein | Serotonin 1a (5-HT1a) receptor | Rattus norvegicus | Ki | = | 10000 | nM | 8568799 |
NPT4913 | Individual Protein | Beta-1 adrenergic receptor | Cavia porcellus | Kd | = | 158.49 | nM | 1361581 |
NPT4913 | Individual Protein | Beta-1 adrenergic receptor | Cavia porcellus | Kd | = | 23.99 | nM | 2872332 |
NPT4914 | Individual Protein | Beta-2 adrenergic receptor | Cavia porcellus | Kd | = | 1174.9 | nM | 2872332 |
NPT5860 | Others | Adrenergic receptor beta; ADRB1 & ADRB2 | Homo sapiens | Ratio | = | 49 | 2872332 | |
NPT218 | Individual Protein | Adenosine A3 receptor | Homo sapiens | IC50 | = | 1.77 | nM | 16250647 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 79.01 | mmHg | 19036593 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 63.44 | mmHg | 19036593 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 65.24 | mmHg | 19036593 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 69.93 | mmHg | 19036593 |
NPT613 | Individual Protein | Solute carrier family 22 member 1 | Homo sapiens | Inhibition | = | -4.6 | % | 18788725 |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | IC50 | = | 600 | nM | 18983139 |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | Ki | = | 430 | nM | 18983139 |
NPT5538 | Individual Protein | Fatty acid-binding protein, liver | Rattus norvegicus | Ki | = | 717000 | nM | 18533710 |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | IC50 | = | 1740 | nM | 18588282 |
NPT605 | Organism | Homo sapiens | Homo sapiens | Activity | = | 0.5 | % | 20022146 |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 5 | nM | PubChem BioAssay data set |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 70.8 | nM | PubChem BioAssay data set |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | IC50 | = | 1640 | nM | 20875743 |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | 163.6 | nM | PubChem BioAssay data set | |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | 8492.1 | nM | PubChem BioAssay data set | |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Ratio | = | 1.49 | 21764308 | |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | Ki | = | 170 | nM | 21726069 |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | 597.3 | nM | PubChem BioAssay data set | |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | IC50 | = | 1313 | nM | DrugMatrix in vitro pharmacology data |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | Ki | = | 758 | nM | DrugMatrix in vitro pharmacology data |
NPT226 | Individual Protein | Beta-2 adrenergic receptor | Homo sapiens | IC50 | = | 14634 | nM | DrugMatrix in vitro pharmacology data |
NPT226 | Individual Protein | Beta-2 adrenergic receptor | Homo sapiens | Ki | = | 10061 | nM | DrugMatrix in vitro pharmacology data |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Ratio | = | 1.75 | 22464423 | |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Ratio | = | 0.57 | 22464423 | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 3162.3 | nM | PubChem BioAssay data set | |
NPT622 | Individual Protein | Solute carrier organic anion transporter family member 2B1 | Homo sapiens | Inhibition | = | 6.8 | % | 22541068 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 7.1 | % | 22541068 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 20.6 | % | 22541068 |
NPT2 | Others | Unspecified | Inhibition | > | 70 | % | 10.1007/s00044-010-9454-7 | |
NPT2 | Others | Unspecified | Ki | = | 185000 | nM | 10.1007/s00044-010-9454-7 | |
NPT2 | Others | Unspecified | IC50 | = | 375000 | nM | 10.1007/s00044-010-9454-7 | |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 230 | nM | 23582449 | |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | Ki | = | 150 | nM | 23466604 |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | IC50 | = | 260 | nM | 23466604 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 78.26 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 93.81 | % | 23571415 |
NPT2 | Others | Unspecified | Potency | 611.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2454.1 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 194.9 | nM | PubChem BioAssay data set | |
NPT4914 | Individual Protein | Beta-2 adrenergic receptor | Cavia porcellus | Kd | = | 1258.93 | nM | 31474 |
NPT4913 | Individual Protein | Beta-1 adrenergic receptor | Cavia porcellus | Kd | = | 43.65 | nM | 31474 |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Ratio | = | 3.7 | 26344593 | |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Ratio | = | 3.7 | 26363868 | |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | Ratio | = | 0.76 | 26741854 | |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | IC50 | = | 210 | nM | 26988801 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC307123 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC247018 |
1.0 | High Similarity | NPC97870 |
0.9516 | High Similarity | NPC320242 |
0.9206 | High Similarity | NPC136112 |
0.9206 | High Similarity | NPC141739 |
0.8467 | Intermediate Similarity | NPC318591 |
0.8467 | Intermediate Similarity | NPC231163 |
0.8417 | Intermediate Similarity | NPC204546 |
0.8102 | Intermediate Similarity | NPC274732 |
0.8031 | Intermediate Similarity | NPC26524 |
0.7958 | Intermediate Similarity | NPC212850 |
0.7958 | Intermediate Similarity | NPC189724 |
0.7958 | Intermediate Similarity | NPC83289 |
0.791 | Intermediate Similarity | NPC328267 |
0.7867 | Intermediate Similarity | NPC233926 |
0.7785 | Intermediate Similarity | NPC47672 |
0.7755 | Intermediate Similarity | NPC245974 |
0.7742 | Intermediate Similarity | NPC108875 |
0.7742 | Intermediate Similarity | NPC38079 |
0.774 | Intermediate Similarity | NPC247298 |
0.7714 | Intermediate Similarity | NPC471953 |
0.768 | Intermediate Similarity | NPC470393 |
0.7656 | Intermediate Similarity | NPC46844 |
0.7638 | Intermediate Similarity | NPC97811 |
0.7634 | Intermediate Similarity | NPC10286 |
0.7634 | Intermediate Similarity | NPC213 |
0.7612 | Intermediate Similarity | NPC263835 |
0.7597 | Intermediate Similarity | NPC166837 |
0.7591 | Intermediate Similarity | NPC95733 |
0.7591 | Intermediate Similarity | NPC62101 |
0.7589 | Intermediate Similarity | NPC470392 |
0.7574 | Intermediate Similarity | NPC298486 |
0.7559 | Intermediate Similarity | NPC194034 |
0.7537 | Intermediate Similarity | NPC256369 |
0.7536 | Intermediate Similarity | NPC29477 |
0.7532 | Intermediate Similarity | NPC37205 |
0.7532 | Intermediate Similarity | NPC160931 |
0.7518 | Intermediate Similarity | NPC326599 |
0.7518 | Intermediate Similarity | NPC329595 |
0.7516 | Intermediate Similarity | NPC156311 |
0.7466 | Intermediate Similarity | NPC168861 |
0.744 | Intermediate Similarity | NPC51633 |
0.7422 | Intermediate Similarity | NPC251306 |
0.7419 | Intermediate Similarity | NPC100870 |
0.7407 | Intermediate Similarity | NPC283760 |
0.7407 | Intermediate Similarity | NPC43275 |
0.7405 | Intermediate Similarity | NPC115379 |
0.7402 | Intermediate Similarity | NPC42383 |
0.74 | Intermediate Similarity | NPC132771 |
0.7391 | Intermediate Similarity | NPC13020 |
0.7391 | Intermediate Similarity | NPC211218 |
0.7391 | Intermediate Similarity | NPC140359 |
0.7381 | Intermediate Similarity | NPC192596 |
0.7364 | Intermediate Similarity | NPC146530 |
0.7353 | Intermediate Similarity | NPC321133 |
0.7351 | Intermediate Similarity | NPC324081 |
0.7348 | Intermediate Similarity | NPC301735 |
0.7343 | Intermediate Similarity | NPC208757 |
0.7338 | Intermediate Similarity | NPC206372 |
0.7338 | Intermediate Similarity | NPC203424 |
0.7329 | Intermediate Similarity | NPC204848 |
0.7329 | Intermediate Similarity | NPC41473 |
0.7329 | Intermediate Similarity | NPC14600 |
0.7329 | Intermediate Similarity | NPC312770 |
0.7329 | Intermediate Similarity | NPC160607 |
0.7305 | Intermediate Similarity | NPC191302 |
0.7305 | Intermediate Similarity | NPC153990 |
0.7299 | Intermediate Similarity | NPC83279 |
0.7297 | Intermediate Similarity | NPC195814 |
0.729 | Intermediate Similarity | NPC56635 |
0.7278 | Intermediate Similarity | NPC158900 |
0.7273 | Intermediate Similarity | NPC114102 |
0.7266 | Intermediate Similarity | NPC255253 |
0.7266 | Intermediate Similarity | NPC8302 |
0.7259 | Intermediate Similarity | NPC137096 |
0.7259 | Intermediate Similarity | NPC120075 |
0.7252 | Intermediate Similarity | NPC137685 |
0.725 | Intermediate Similarity | NPC186617 |
0.7239 | Intermediate Similarity | NPC303370 |
0.7237 | Intermediate Similarity | NPC115144 |
0.7237 | Intermediate Similarity | NPC277857 |
0.7234 | Intermediate Similarity | NPC323775 |
0.7234 | Intermediate Similarity | NPC236347 |
0.7233 | Intermediate Similarity | NPC254700 |
0.7231 | Intermediate Similarity | NPC309982 |
0.7226 | Intermediate Similarity | NPC17388 |
0.7226 | Intermediate Similarity | NPC53596 |
0.7226 | Intermediate Similarity | NPC160120 |
0.7226 | Intermediate Similarity | NPC471308 |
0.7226 | Intermediate Similarity | NPC289330 |
0.7222 | Intermediate Similarity | NPC130595 |
0.7222 | Intermediate Similarity | NPC93882 |
0.7219 | Intermediate Similarity | NPC313414 |
0.7211 | Intermediate Similarity | NPC474673 |
0.7205 | Intermediate Similarity | NPC471568 |
0.7205 | Intermediate Similarity | NPC473693 |
0.7205 | Intermediate Similarity | NPC196091 |
0.72 | Intermediate Similarity | NPC78530 |
0.72 | Intermediate Similarity | NPC63628 |
0.72 | Intermediate Similarity | NPC178466 |
0.7197 | Intermediate Similarity | NPC21890 |
0.7197 | Intermediate Similarity | NPC55300 |
0.7194 | Intermediate Similarity | NPC71090 |
0.7192 | Intermediate Similarity | NPC64205 |
0.7192 | Intermediate Similarity | NPC470471 |
0.719 | Intermediate Similarity | NPC76412 |
0.7188 | Intermediate Similarity | NPC226778 |
0.7188 | Intermediate Similarity | NPC147000 |
0.7188 | Intermediate Similarity | NPC150254 |
0.7188 | Intermediate Similarity | NPC304761 |
0.7185 | Intermediate Similarity | NPC258992 |
0.7183 | Intermediate Similarity | NPC186898 |
0.7183 | Intermediate Similarity | NPC198798 |
0.7176 | Intermediate Similarity | NPC474272 |
0.7176 | Intermediate Similarity | NPC145638 |
0.7176 | Intermediate Similarity | NPC290566 |
0.7176 | Intermediate Similarity | NPC24777 |
0.7174 | Intermediate Similarity | NPC318357 |
0.7174 | Intermediate Similarity | NPC183262 |
0.7172 | Intermediate Similarity | NPC313737 |
0.7172 | Intermediate Similarity | NPC6854 |
0.7172 | Intermediate Similarity | NPC285078 |
0.7164 | Intermediate Similarity | NPC235250 |
0.7164 | Intermediate Similarity | NPC118202 |
0.7162 | Intermediate Similarity | NPC299583 |
0.7154 | Intermediate Similarity | NPC186469 |
0.7153 | Intermediate Similarity | NPC163036 |
0.7152 | Intermediate Similarity | NPC294249 |
0.7143 | Intermediate Similarity | NPC258222 |
0.7143 | Intermediate Similarity | NPC165646 |
0.7133 | Intermediate Similarity | NPC271808 |
0.7133 | Intermediate Similarity | NPC155838 |
0.7132 | Intermediate Similarity | NPC164386 |
0.7132 | Intermediate Similarity | NPC323948 |
0.7132 | Intermediate Similarity | NPC473855 |
0.7125 | Intermediate Similarity | NPC469479 |
0.7123 | Intermediate Similarity | NPC218530 |
0.7122 | Intermediate Similarity | NPC127389 |
0.7122 | Intermediate Similarity | NPC290451 |
0.7122 | Intermediate Similarity | NPC211992 |
0.7114 | Intermediate Similarity | NPC477838 |
0.7114 | Intermediate Similarity | NPC477837 |
0.7113 | Intermediate Similarity | NPC301713 |
0.7111 | Intermediate Similarity | NPC317254 |
0.7109 | Intermediate Similarity | NPC305205 |
0.7107 | Intermediate Similarity | NPC22014 |
0.7103 | Intermediate Similarity | NPC214869 |
0.7101 | Intermediate Similarity | NPC41801 |
0.7101 | Intermediate Similarity | NPC60589 |
0.7101 | Intermediate Similarity | NPC469708 |
0.7097 | Intermediate Similarity | NPC476742 |
0.7097 | Intermediate Similarity | NPC469711 |
0.7095 | Intermediate Similarity | NPC470470 |
0.7095 | Intermediate Similarity | NPC253429 |
0.7095 | Intermediate Similarity | NPC214988 |
0.7092 | Intermediate Similarity | NPC94276 |
0.7092 | Intermediate Similarity | NPC48990 |
0.7092 | Intermediate Similarity | NPC293701 |
0.7092 | Intermediate Similarity | NPC114901 |
0.7092 | Intermediate Similarity | NPC109822 |
0.7083 | Intermediate Similarity | NPC262641 |
0.7083 | Intermediate Similarity | NPC52029 |
0.7083 | Intermediate Similarity | NPC195749 |
0.7083 | Intermediate Similarity | NPC35961 |
0.708 | Intermediate Similarity | NPC101503 |
0.708 | Intermediate Similarity | NPC5932 |
0.7078 | Intermediate Similarity | NPC470935 |
0.7078 | Intermediate Similarity | NPC471032 |
0.7075 | Intermediate Similarity | NPC237227 |
0.7075 | Intermediate Similarity | NPC6570 |
0.7071 | Intermediate Similarity | NPC471314 |
0.7071 | Intermediate Similarity | NPC471315 |
0.707 | Intermediate Similarity | NPC2295 |
0.707 | Intermediate Similarity | NPC477564 |
0.707 | Intermediate Similarity | NPC212699 |
0.707 | Intermediate Similarity | NPC207675 |
0.7063 | Intermediate Similarity | NPC157740 |
0.7063 | Intermediate Similarity | NPC107619 |
0.7063 | Intermediate Similarity | NPC99798 |
0.7063 | Intermediate Similarity | NPC251571 |
0.7063 | Intermediate Similarity | NPC313918 |
0.7051 | Intermediate Similarity | NPC76213 |
0.7051 | Intermediate Similarity | NPC476741 |
0.7051 | Intermediate Similarity | NPC277669 |
0.705 | Intermediate Similarity | NPC269242 |
0.705 | Intermediate Similarity | NPC198734 |
0.705 | Intermediate Similarity | NPC469412 |
0.7047 | Intermediate Similarity | NPC36434 |
0.7042 | Intermediate Similarity | NPC194519 |
0.7034 | Intermediate Similarity | NPC308885 |
0.7034 | Intermediate Similarity | NPC255550 |
0.7032 | Intermediate Similarity | NPC60538 |
0.7032 | Intermediate Similarity | NPC207824 |
0.7031 | Intermediate Similarity | NPC327226 |
0.7029 | Intermediate Similarity | NPC135961 |
0.7029 | Intermediate Similarity | NPC311595 |
0.7029 | Intermediate Similarity | NPC24474 |
0.7025 | Intermediate Similarity | NPC319320 |
0.7025 | Intermediate Similarity | NPC287757 |
0.7023 | Intermediate Similarity | NPC258171 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC307123 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD1423 | Approved |
0.9516 | High Similarity | NPD1819 | Approved |
0.9516 | High Similarity | NPD1818 | Approved |
0.9516 | High Similarity | NPD1820 | Approved |
0.9516 | High Similarity | NPD1817 | Approved |
0.9219 | High Similarity | NPD3167 | Approved |
0.9219 | High Similarity | NPD3165 | Approved |
0.9219 | High Similarity | NPD3166 | Approved |
0.9219 | High Similarity | NPD3164 | Approved |
0.9206 | High Similarity | NPD1794 | Approved |
0.907 | High Similarity | NPD3179 | Approved |
0.907 | High Similarity | NPD3180 | Approved |
0.8815 | High Similarity | NPD3175 | Clinical (unspecified phase) |
0.8676 | High Similarity | NPD2239 | Approved |
0.8676 | High Similarity | NPD2240 | Approved |
0.8647 | High Similarity | NPD3163 | Approved |
0.8647 | High Similarity | NPD3162 | Approved |
0.8615 | High Similarity | NPD1770 | Clinical (unspecified phase) |
0.8582 | High Similarity | NPD3985 | Discontinued |
0.8582 | High Similarity | NPD3597 | Clinical (unspecified phase) |
0.8467 | Intermediate Similarity | NPD2156 | Approved |
0.8467 | Intermediate Similarity | NPD2155 | Approved |
0.8467 | Intermediate Similarity | NPD2154 | Approved |
0.8456 | Intermediate Similarity | NPD3052 | Approved |
0.8456 | Intermediate Similarity | NPD3054 | Approved |
0.8433 | Intermediate Similarity | NPD3056 | Clinical (unspecified phase) |
0.8359 | Intermediate Similarity | NPD1798 | Approved |
0.8359 | Intermediate Similarity | NPD1797 | Approved |
0.8357 | Intermediate Similarity | NPD2460 | Phase 3 |
0.8357 | Intermediate Similarity | NPD2458 | Approved |
0.8357 | Intermediate Similarity | NPD2459 | Approved |
0.8346 | Intermediate Similarity | NPD2250 | Discontinued |
0.8239 | Intermediate Similarity | NPD2677 | Approved |
0.8227 | Intermediate Similarity | NPD4162 | Approved |
0.8194 | Intermediate Similarity | NPD6419 | Discontinued |
0.8194 | Intermediate Similarity | NPD3536 | Discontinued |
0.8138 | Intermediate Similarity | NPD7527 | Clinical (unspecified phase) |
0.8138 | Intermediate Similarity | NPD7526 | Approved |
0.8138 | Intermediate Similarity | NPD52 | Approved |
0.8125 | Intermediate Similarity | NPD1774 | Approved |
0.8095 | Intermediate Similarity | NPD821 | Approved |
0.8088 | Intermediate Similarity | NPD5163 | Phase 2 |
0.8074 | Intermediate Similarity | NPD5266 | Clinical (unspecified phase) |
0.8069 | Intermediate Similarity | NPD2874 | Phase 2 |
0.7986 | Intermediate Similarity | NPD5160 | Discontinued |
0.7972 | Intermediate Similarity | NPD5061 | Approved |
0.7972 | Intermediate Similarity | NPD5062 | Approved |
0.7971 | Intermediate Similarity | NPD3532 | Approved |
0.7971 | Intermediate Similarity | NPD3530 | Approved |
0.7971 | Intermediate Similarity | NPD3531 | Approved |
0.7956 | Intermediate Similarity | NPD6179 | Discontinued |
0.791 | Intermediate Similarity | NPD2428 | Approved |
0.791 | Intermediate Similarity | NPD2429 | Approved |
0.7902 | Intermediate Similarity | NPD7153 | Discontinued |
0.7899 | Intermediate Similarity | NPD1336 | Approved |
0.7879 | Intermediate Similarity | NPD2554 | Approved |
0.7879 | Intermediate Similarity | NPD2556 | Approved |
0.7867 | Intermediate Similarity | NPD6677 | Suspended |
0.7847 | Intermediate Similarity | NPD1416 | Approved |
0.7786 | Intermediate Similarity | NPD856 | Approved |
0.7786 | Intermediate Similarity | NPD318 | Approved |
0.7786 | Intermediate Similarity | NPD5837 | Clinical (unspecified phase) |
0.7786 | Intermediate Similarity | NPD16 | Approved |
0.7786 | Intermediate Similarity | NPD317 | Approved |
0.7778 | Intermediate Similarity | NPD3676 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD1372 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD2684 | Approved |
0.7778 | Intermediate Similarity | NPD3685 | Discontinued |
0.777 | Intermediate Similarity | NPD2236 | Approved |
0.777 | Intermediate Similarity | NPD2676 | Approved |
0.777 | Intermediate Similarity | NPD2675 | Approved |
0.7763 | Intermediate Similarity | NPD3465 | Clinical (unspecified phase) |
0.7762 | Intermediate Similarity | NPD1422 | Approved |
0.7755 | Intermediate Similarity | NPD6087 | Phase 1 |
0.7724 | Intermediate Similarity | NPD3060 | Approved |
0.7724 | Intermediate Similarity | NPD2976 | Clinical (unspecified phase) |
0.7714 | Intermediate Similarity | NPD1726 | Clinical (unspecified phase) |
0.7714 | Intermediate Similarity | NPD5745 | Approved |
0.771 | Intermediate Similarity | NPD3596 | Phase 2 |
0.7707 | Intermediate Similarity | NPD2215 | Approved |
0.7707 | Intermediate Similarity | NPD2216 | Approved |
0.7704 | Intermediate Similarity | NPD2231 | Phase 2 |
0.7704 | Intermediate Similarity | NPD2561 | Approved |
0.7704 | Intermediate Similarity | NPD2235 | Phase 2 |
0.7704 | Intermediate Similarity | NPD2562 | Approved |
0.7703 | Intermediate Similarity | NPD4662 | Approved |
0.7703 | Intermediate Similarity | NPD4661 | Approved |
0.7697 | Intermediate Similarity | NPD5722 | Discontinued |
0.7697 | Intermediate Similarity | NPD4018 | Clinical (unspecified phase) |
0.7692 | Intermediate Similarity | NPD3152 | Clinical (unspecified phase) |
0.7692 | Intermediate Similarity | NPD593 | Approved |
0.7692 | Intermediate Similarity | NPD595 | Approved |
0.7669 | Intermediate Similarity | NPD3049 | Approved |
0.7652 | Intermediate Similarity | NPD1103 | Approved |
0.7652 | Intermediate Similarity | NPD1102 | Approved |
0.7647 | Intermediate Similarity | NPD6582 | Phase 2 |
0.7647 | Intermediate Similarity | NPD5772 | Approved |
0.7647 | Intermediate Similarity | NPD5773 | Approved |
0.7647 | Intermediate Similarity | NPD6583 | Phase 3 |
0.7632 | Intermediate Similarity | NPD6072 | Discontinued |
0.7632 | Intermediate Similarity | NPD2541 | Clinical (unspecified phase) |
0.7616 | Intermediate Similarity | NPD2649 | Approved |
0.7616 | Intermediate Similarity | NPD2651 | Approved |
0.7615 | Intermediate Similarity | NPD592 | Approved |
0.7615 | Intermediate Similarity | NPD594 | Approved |
0.7606 | Intermediate Similarity | NPD1341 | Clinical (unspecified phase) |
0.7603 | Intermediate Similarity | NPD4237 | Approved |
0.7603 | Intermediate Similarity | NPD4236 | Phase 3 |
0.7584 | Intermediate Similarity | NPD5348 | Clinical (unspecified phase) |
0.7584 | Intermediate Similarity | NPD1771 | Clinical (unspecified phase) |
0.7571 | Intermediate Similarity | NPD5746 | Approved |
0.7568 | Intermediate Similarity | NPD3122 | Phase 3 |
0.7559 | Intermediate Similarity | NPD290 | Approved |
0.7554 | Intermediate Similarity | NPD4993 | Discontinued |
0.755 | Intermediate Similarity | NPD3687 | Approved |
0.755 | Intermediate Similarity | NPD3686 | Approved |
0.7538 | Intermediate Similarity | NPD7843 | Approved |
0.7533 | Intermediate Similarity | NPD5261 | Clinical (unspecified phase) |
0.7518 | Intermediate Similarity | NPD597 | Approved |
0.7518 | Intermediate Similarity | NPD598 | Approved |
0.7518 | Intermediate Similarity | NPD601 | Approved |
0.7517 | Intermediate Similarity | NPD1725 | Approved |
0.7516 | Intermediate Similarity | NPD4666 | Phase 3 |
0.75 | Intermediate Similarity | NPD8031 | Discontinued |
0.75 | Intermediate Similarity | NPD3552 | Approved |
0.75 | Intermediate Similarity | NPD3555 | Approved |
0.75 | Intermediate Similarity | NPD3553 | Approved |
0.75 | Intermediate Similarity | NPD3554 | Approved |
0.7482 | Intermediate Similarity | NPD3690 | Phase 2 |
0.7482 | Intermediate Similarity | NPD558 | Phase 2 |
0.7482 | Intermediate Similarity | NPD3691 | Phase 2 |
0.7482 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7465 | Intermediate Similarity | NPD840 | Approved |
0.7465 | Intermediate Similarity | NPD1136 | Approved |
0.7465 | Intermediate Similarity | NPD1130 | Approved |
0.7465 | Intermediate Similarity | NPD1132 | Approved |
0.7465 | Intermediate Similarity | NPD839 | Approved |
0.7463 | Intermediate Similarity | NPD6580 | Approved |
0.7463 | Intermediate Similarity | NPD6581 | Approved |
0.7452 | Intermediate Similarity | NPD5709 | Phase 3 |
0.745 | Intermediate Similarity | NPD5756 | Phase 2 |
0.7431 | Intermediate Similarity | NPD2223 | Approved |
0.7431 | Intermediate Similarity | NPD2224 | Approved |
0.7419 | Intermediate Similarity | NPD2977 | Approved |
0.7419 | Intermediate Similarity | NPD2978 | Approved |
0.741 | Intermediate Similarity | NPD1129 | Approved |
0.741 | Intermediate Similarity | NPD1131 | Approved |
0.741 | Intermediate Similarity | NPD1133 | Approved |
0.741 | Intermediate Similarity | NPD1135 | Approved |
0.741 | Intermediate Similarity | NPD1134 | Approved |
0.7407 | Intermediate Similarity | NPD6830 | Clinical (unspecified phase) |
0.7397 | Intermediate Similarity | NPD2161 | Phase 2 |
0.7394 | Intermediate Similarity | NPD3374 | Clinical (unspecified phase) |
0.7394 | Intermediate Similarity | NPD1048 | Approved |
0.7389 | Intermediate Similarity | NPD8070 | Approved |
0.7383 | Intermediate Similarity | NPD3692 | Discontinued |
0.7376 | Intermediate Similarity | NPD600 | Approved |
0.7376 | Intermediate Similarity | NPD596 | Approved |
0.7368 | Intermediate Similarity | NPD7157 | Approved |
0.7368 | Intermediate Similarity | NPD2557 | Approved |
0.7368 | Intermediate Similarity | NPD7131 | Phase 3 |
0.7358 | Intermediate Similarity | NPD7485 | Phase 3 |
0.7358 | Intermediate Similarity | NPD7484 | Phase 3 |
0.7353 | Intermediate Similarity | NPD2667 | Approved |
0.7353 | Intermediate Similarity | NPD2668 | Approved |
0.7351 | Intermediate Similarity | NPD2504 | Approved |
0.7351 | Intermediate Similarity | NPD2505 | Approved |
0.7343 | Intermediate Similarity | NPD7477 | Discontinued |
0.7343 | Intermediate Similarity | NPD2245 | Discovery |
0.7342 | Intermediate Similarity | NPD6315 | Phase 2 |
0.7338 | Intermediate Similarity | NPD4179 | Approved |
0.7338 | Intermediate Similarity | NPD4180 | Approved |
0.7333 | Intermediate Similarity | NPD316 | Approved |
0.7333 | Intermediate Similarity | NPD5295 | Discontinued |
0.7329 | Intermediate Similarity | NPD2661 | Clinical (unspecified phase) |
0.7325 | Intermediate Similarity | NPD4581 | Clinical (unspecified phase) |
0.7305 | Intermediate Similarity | NPD3154 | Approved |
0.7305 | Intermediate Similarity | NPD1712 | Approved |
0.7305 | Intermediate Similarity | NPD455 | Discontinued |
0.7305 | Intermediate Similarity | NPD3153 | Approved |
0.7297 | Intermediate Similarity | NPD1391 | Approved |
0.7279 | Intermediate Similarity | NPD6032 | Approved |
0.7279 | Intermediate Similarity | NPD3156 | Discontinued |
0.7267 | Intermediate Similarity | NPD5241 | Discontinued |
0.7266 | Intermediate Similarity | NPD6542 | Approved |
0.7266 | Intermediate Similarity | NPD6543 | Approved |
0.7266 | Intermediate Similarity | NPD6540 | Phase 3 |
0.7266 | Intermediate Similarity | NPD6539 | Approved |
0.7261 | Intermediate Similarity | NPD3556 | Approved |
0.7261 | Intermediate Similarity | NPD3560 | Approved |
0.7261 | Intermediate Similarity | NPD3559 | Clinical (unspecified phase) |
0.7261 | Intermediate Similarity | NPD3558 | Approved |
0.7261 | Intermediate Similarity | NPD3557 | Approved |
0.7259 | Intermediate Similarity | NPD9616 | Approved |
0.7259 | Intermediate Similarity | NPD9613 | Approved |
0.7259 | Intermediate Similarity | NPD9615 | Approved |
0.7254 | Intermediate Similarity | NPD5752 | Clinical (unspecified phase) |
0.7246 | Intermediate Similarity | NPD776 | Approved |
0.7244 | Intermediate Similarity | NPD5356 | Approved |
0.7244 | Intermediate Similarity | NPD5355 | Approved |
Molecular Weight:   | 266.16 |
ALogP:   | -1.0566 |
MLogP:   | 2.45 |
XLogP:   | 1.812 |
# Rotatable Bonds:   | 12 |
Polar Surface Area:   | 85.57 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 4 |
# Rings:   | 1 |
# Heavy Atoms:   | 19 |